Julius Baer Gruppe AG (0QO6)
London Exchange · UK · prices in GBP · close of 19 Oct 2026
Key indicators
| Last close | GBP 70.23 |
|---|---|
| 52-week range | 51.74 – 78.14 |
| Return, 1 month / 3 months | −4.2% / −1.4% |
| Return, 1 year / 3 years | +29.5% / +24.7% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 43 |
| Volatility (1 year) | 27.9% |
| Worst drawdown (1 year) | -17.9% |
| Average daily value traded | 12.61M GBP |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Julius Baer Gruppe AG is a Swiss private banking group based in Zurich that focuses on wealth management for private clients. It offers investment advice, portfolio management, wealth planning and related financial services to wealthy individuals and families, as well as to external asset managers and institutional clients. The bank operates through a network of offices and subsidiaries in Switzerland and in many other countries, serving clients with international and cross-border needs.
Julius Baer Gruppe AG trades under the code 0QO6 on the London Exchange in UK, with its price quoted in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Julius Baer Gruppe AG (0QO6) trades on the London Exchange in UK. It last closed at GBP 70.23 on 19 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 825 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 29.5% and over the last three months it fell 1.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 69 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.9% | ||
| From 52-week high | -9.1% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -1.4% | ||
| 6-month return | 10.4% | ||
| 12-month return, skipping the last month | 35.3% | ||
| Stability (higher is calmer) | 73 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 27.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.9% | ||
| Liquidity | 76 · Strong | Trades actively. | |
| Average daily value traded | 12.61M GBP | ||
| Zero-volume days | 0.0% | ||
| Income | 29 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.8% |
|---|---|
| 1 month | −4.2% |
| 3 months | −1.4% |
| 6 months | +10.4% |
| 1 year | +29.5% |
| 3 years | +24.7% |
| 5 years | – |
Signals
| 50-day / 200-day average | 73.55 / 67.60 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 1.82 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Apr 2026 | GBX 0.0260 |
| 14 Apr 2025 | GBX 0.0260 |
| 15 Apr 2024 | GBX 0.0260 |
| 17 Apr 2023 | GBX 0.0260 |
| 14 Apr 2022 | GBX 0.0110 |
| 16 Apr 2021 | GBX 0.0111 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.